En esta página
01SNDX precio
02Instantánea
03Gráfico
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
23Noticias
26Mis Métricas
SNDX Syndax Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 4, 2026
$17,60
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$12,99mínimo 52 semanas
$25,59máximo 52 semanas
Capitalización Bursátil (MRQ)
$1.57B
P/E (TTM)
-7.0
BPA (TTM)
$-2.51
Ingresos (TTM)
$252M
tus insignias
Rango 52S
$13–$26
Calificación del Analista
BUY
Precio Objetivo
$38
P/E
-7.0
ROE
-255.9%
Margen de Beneficio Neto
-87.6%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
SNDX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$17.60
Capitalización Bursátil (MRQ)
$1.57B
P/E (TTM)
-7.0
BPA (TTM)
$-2.51
Ingresos (TTM)
$252M
ROE (TTM)
-255.9%
Deuda/Capital (MRQ)
23.2
Rango 52S
$13–$26
SNDX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$172M2016-12-31 → 2025-12-31
BPA$-3.292019-12-31 → 2025-12-31
Flujo de caja libre$-323M2016-12-31 → 2025-12-31
Margen neto-87.6%2016-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | SNDX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -7.0promedio 5A ≈4.0 | ≈4.0 | · | · | |
| P/S (TTM) | 6.2promedio 5A ≈22.4 | ≈22.4 | 62.1 | Infravalorado | |
| P/C (MRQ) | 103.9promedio 5A ≈8.5 | ≈8.5 | 5.7 | Sobrevalorado | |
| EV / EBITDA | -5.5 | · | · | · | |
| Price / FCF (Precio / FCF) | -4.8promedio 5A ≈2.9 | ≈2.9 | · | · | |
| Price / Cash Flow (Precio / Flujo de Caja) | -4.8promedio 5A ≈1.4 | ≈1.4 | · | · | |
| EV / Ingresos (TTM) | 5.4 | · | · | · | |
| EV / FCF | -4.6 | · | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 23.8promedio 5A ≈8.5 | ≈8.5 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | SNDX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -77.1%promedio 5A ≈-524.7% | ≈-524.7% | -1024.8% | De primer nivel | |
| EBITDA Margin (Margen EBITDA) | -158.4%promedio 5A ≈-524.7% | ≈-524.7% | -1024.8% | De primer nivel | |
| Margen de Beneficio Neto (TTM) | -87.6%promedio 5A ≈-498.0% | ≈-498.0% | -1048.0% | De primer nivel | |
| ROA (TTM) | -34.0%promedio 5A ≈-31.2% | ≈-31.2% | -40.6% | Débil | |
| ROE (TTM) | -255.9%promedio 5A ≈-85.8% | ≈-85.8% | -44.0% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | SNDX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Deuda / Patrimonio (MRQ) | 23.2 | · | 0.1 | Deuda alta | |
| Ratio corriente (MRQ) | 6.8promedio 5A ≈11.7 | ≈11.7 | 7.2 | En línea | |
| Quick Ratio (Ratio Rápido) | 3.6promedio 5A ≈11.3 | ≈11.3 | 5.1 | En línea |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | SNDX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 627.8% | · | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | -44.7% | · | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | 157.7% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | SNDX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.3promedio 5A ≈0.2 | ≈0.2 | 0.1 | De primer nivel | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 7.6 | · | 5.8 | De primer nivel | |
| Revenue / Employee (Ingresos / Empleado) | ≈$578.4K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
3.0%
Próximo informe
Nov 02, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 3, 2026 | $-0.55 | $-0.45 | -21.9% |
| 31 de marzo de 2026 | May 11, 2026 | $-0.48 | $-0.59 | 19.2% |
| 31 de diciembre de 2025 | $-0.78 | $-0.60 | -30.9% | |
| 30 de septiembre de 2025 | $-0.70 | $-0.73 | 4.2% | |
| 30 de junio de 2025 | $-0.83 | $-1.04 | 19.9% | |
| 31 de marzo de 2025 | $-0.98 | $-1.36 | 27.8% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $172M | $24M | $0 | $0 | $140M | $2M | $2M | $2M | $2M | $1M | $627.0K | |
| R&D Expense | $259M | $242M | $163M | $118M | $88M | $50M | $43M | $60M | $48M | $32M | $10M | |
| SG&A Expense | $180M | $121M | $67M | $33M | $25M | $23M | $16M | $17M | $16M | $13M | $12M | |
| Operating Expenses | $445M | $363M | $230M | $152M | $113M | $73M | $59M | $77M | $64M | $45M | $21M | |
| Operating Income | $-273M | $-340M | $-230M | $-152M | $26M | $-71M | $-58M | $-76M | $-62M | $-44M | $-21M | |
| Interest Expense | · | · | $208.0K | $3M | $2M | $2M | · | · | · | · | · | |
| Interest Income | $23M | $26M | $21M | $6M | $403.0K | $841.0K | $2M | $2M | · | · | · | |
| Other Non-op | $-1M | $-247.0K | $-361.0K | $-316.0K | $202.0K | $-219.0K | $-79.0K | $-27.0K | $-269.0K | $41.0K | $-37.0K | |
| Income Tax | $433.0K | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-285M | $-319M | $-209M | $-149M | $25M | $-73M | $-56M | $-74M | $-61M | $-44M | $-24M | |
| EPS (Basic) | $-3.29 | $-3.72 | $-2.98 | $-2.46 | $0.48 | $-1.87 | $-1.84 | · | · | · | · | |
| EPS (Diluted) | $-3.29 | $-3.72 | $-2.98 | $-2.46 | $0.46 | $-1.87 | $-1.84 | · | · | · | · | |
| Shares (Basic) | 86,625,610 | 85,622,065 | 70,370,519 | 60,760,906 | 52,064,809 | 41,308,242 | 30,490,783 | · | · | · | · | |
| Shares (Diluted) | 86,625,610 | 85,622,065 | 70,370,519 | 60,760,906 | 53,622,904 | 41,308,242 | 30,490,783 | · | · | · | · | |
| EBITDA | $-273M | $-340M | $-230M | $-152M | $26M | · | $-58M | · | $-62M | $-44M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $135M | $154M | $295M | $74M | $222M | $115M | $25M | $34M | $35M | $24M | $23M | |
| Short-term Investments | $259M | $419M | $275M | $401M | $218M | $178M | $35M | $47M | $95M | $81M | $63M | |
| Receivables | $38M | $8M | $0 | · | · | · | · | · | · | · | · | |
| Inventory | $33M | $366.0K | $0 | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $13M | $9M | $3M | $2M | $1M | $6M | $3M | $2M | $3M | $3M | $1M | |
| Other Current Assets | · | · | $0 | · | · | · | · | · | · | · | · | |
| Current Assets | $528M | $603M | $581M | $490M | $448M | $299M | $62M | $83M | $133M | $109M | $88M | |
| PP&E (Net) | $181.0K | $0 | $8.0K | $20.0K | $278.0K | $192.0K | $281.0K | $373.0K | $267.0K | $260.0K | $88.0K | |
| PP&E (Gross) | $606.0K | $419.0K | $419.0K | $419.0K | $721.0K | $591.0K | $591.0K | $608.0K | $466.0K | $540.0K | $280.0K | |
| Accum. Depreciation | $425.0K | $419.0K | $411.0K | $399.0K | $443.0K | $399.0K | $310.0K | $235.0K | $199.0K | $280.0K | $192.0K | |
| Other Non-current Assets | · | $0 | $463.0K | $807.0K | $0 | $1M | $197.0K | $219.0K | $231.0K | $243.0K | $2M | |
| Total Assets | $530M | $725M | $613M | $497M | $450M | $301M | $64M | $84M | $137M | $109M | $90M | |
| Accounts Payable | $17M | $12M | $10M | $4M | $6M | $4M | $6M | $1M | $2M | $2M | $1M | |
| Current Liabilities | $120M | $104M | $58M | $29M | $21M | $19M | $18M | $16M | $16M | $10M | $5M | |
| Capital Leases | · | $2M | $578.0K | $709.0K | $711.0K | $101.0K | $419.0K | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | $1.0K | $5.0K | $136.0K | $310.0K | $288.0K | $70.0K | |
| Total Liabilities | $465M | $437M | $59M | $30M | $41M | $48M | $32M | $31M | $33M | $25M | $23M | |
| Total Debt | $350M | $338M | · | · | · | · | · | · | · | · | · | |
| Common Stock | $9.0K | $9.0K | $8.0K | $7.0K | $6.0K | $5.0K | $3.0K | $2.0K | $2.0K | $2.0K | $1.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | $471M | · | · | |
| Retained Earnings | $-1.51B | $-1.22B | $-902M | $-693M | $-544M | $-569M | $-495M | $-439M | $-366M | $-305M | $-260M | |
| Stockholders' Equity | $65M | $288M | $554M | $467M | $408M | $252M | $32M | $53M | $104M | $84M | $-252M | |
| Liabilities + Equity | $530M | $725M | $613M | $497M | $450M | $301M | $64M | $84M | $137M | $109M | $90M | |
| Shares Outstanding | 87,405,979 | 85,694,443 | 84,826,632 | 68,111,385 | 54,983,105 | 47,881,223 | 27,140,484 | 24,835,951 | 24,390,033 | 18,215,181 | 85,440 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $48M | $43M | $31M | $16M | $13M | $9M | $6M | $6M | $5M | $5M | $4M | |
| Operating Cash Flow | $-323M | $-275M | $-161M | $-134M | $29M | $-71M | $-51M | $-69M | $-47M | $-35M | $-2M | |
| CapEx | $187.0K | $0 | $0 | $0 | $129.0K | $0 | · | $187.0K | $84.0K | $261.0K | $49.0K | |
| Investing Cash Flow | $290M | $-220M | $118M | $-186M | $-41M | $-143M | $13M | $51M | $-17M | $-18M | · | |
| Financing Cash Flow | $14M | $353M | $264M | $172M | $118M | $304M | $29M | $16M | $76M | $54M | · | |
| Net Change in Cash | $-19M | $-141M | $221M | $-148M | $107M | $91M | $-9M | $-1M | $11M | $762.0K | $13M | |
| Taxes Paid | $150 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-323M | · | $-161M | $-134M | $29M | · | · | · | $-47M | $-35M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -158.4% | -1434.4% | · | · | 18.8% | · | -3792.9% | · | -2939.0% | -3587.4% | · | |
| Net Margin | -165.6% | -1346.1% | · | · | 17.8% | · | -3694.6% | · | -2884.3% | -3645.2% | · | |
| EBITDA Margin | -158.4% | -1434.4% | · | · | 18.8% | · | -3792.9% | · | -2939.0% | -3587.4% | · | |
| ROA | -45.5% | -47.7% | -37.7% | -31.5% | 6.6% | · | -76.0% | · | -49.4% | -44.7% | · | |
| ROE | -257.1% | -97.4% | -45.8% | -37.1% | 8.2% | · | -148.2% | · | -64.5% | 52.9% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.4 | 5.8 | 10.0 | 16.9 | 21.7 | · | 3.4 | · | 8.4 | 10.5 | · | |
| Quick Ratio | 3.6 | 5.6 | 9.8 | 16.4 | 21.3 | · | 3.3 | · | 8.2 | 10.2 | · | |
| Debt / Equity | 5.4 | 1.2 | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | -1105.5 | -48.4 | 13.8 | · | · | · | · | · | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.0 | 0.0 | · | 0.4 | · | 0.0 | · | 0.0 | 0.0 | · | |
| Receivables Turnover | 7.6 | 6.2 | · | · | · | · | · | · | · | · | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.74 | $3.36 | $6.53 | $6.86 | $7.43 | · | $1.16 | · | $4.28 | $4.62 | · | |
| Revenue / Share | $1.99 | $0.28 | $0.00 | · | $2.61 | · | · | · | · | · | · | |
| Cash Flow / Share | $-3.73 | $-3.21 | $-2.28 | $-2.20 | $0.54 | · | · | · | · | · | · | |
| Cash / Share | $1.54 | $1.80 | $3.48 | $1.09 | $4.04 | · | $0.91 | · | $1.44 | $1.31 | · | |
| EPS (TTM) | $-3.29 | $-3.72 | $-2.98 | $-2.46 | $0.46 | $-1.87 | $-1.84 | · | · | · | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 627.8% | · | · | · | 9109.6% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | -44.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 157.7% | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $172M | $24M | $0 | $0 | $140M | $2M | $2M | $2M | $2M | $1M | · | |
| Net Income TTM | $-285M | $-319M | $-209M | $-149M | $25M | $-73M | $-56M | $-74M | $-61M | $-44M | · | |
| Market Cap | $1.84B | $1.13B | $1.83B | $1.73B | $1.20B | · | $238M | · | $214M | $131M | · | |
| Enterprise Value | $1.79B | $898M | · | · | · | · | · | · | · | · | · | |
| P/E | -6.4 | -3.6 | -7.3 | -10.3 | 47.6 | -11.9 | -4.8 | · | · | · | · | |
| P/S | 10.7 | 47.8 | · | · | 8.6 | · | 157.1 | · | 101.4 | 107.1 | · | |
| P/B | 28.4 | 3.9 | 3.3 | 3.7 | 2.9 | · | 7.5 | · | 2.0 | 1.6 | · | |
| P / Tangible Book | 28.4 | 3.9 | 3.3 | 3.7 | 2.9 | 4.2 | · | · | · | · | · | |
| P / Cash Flow | -5.7 | -4.1 | -11.4 | -13.0 | 41.3 | · | -4.7 | · | -4.5 | -3.7 | · | |
| P / FCF | -5.7 | · | -11.4 | -13.0 | 41.5 | · | · | · | -4.5 | -3.7 | · | |
| EV / EBITDA | -6.6 | -2.6 | · | · | · | · | · | · | · | · | · | |
| EV / FCF | -5.5 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 10.4 | 37.9 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -15.7% | -28.1% | -13.8% | -9.7% | 2.1% | -8.4% | -21.0% | · | · | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $73M | $65M | $68M | $46M | $38M | $20M | $8M | $12M | $4M | $0 | $0 | $0 | · | · | · | · | |
| R&D Expense | $68M | $59M | $79M | $56M | $62M | $62M | $66M | $71M | $49M | $56M | $39M | $35M | $34M | $27M | $30M | $30M | |
| SG&A Expense | $42M | $38M | $50M | $45M | $44M | $41M | $38M | $31M | $29M | $23M | $17M | $15M | $12M | $8M | $8M | $7M | |
| Operating Expenses | $113M | $99M | $131M | $103M | $107M | $104M | $104M | $102M | $78M | $80M | $56M | $50M | $46M | $35M | $38M | $37M | |
| Operating Income | $-40M | $-34M | $-63M | $-57M | $-69M | $-84M | $-96M | $-90M | $-74M | $-80M | $-56M | $-50M | $-46M | $-35M | $-38M | $-37M | |
| Interest Expense | · | · | · | · | · | · | · | · | $45.0K | $55.0K | $70.0K | $35.0K | $40.0K | $2M | $695.0K | $651.0K | |
| Interest Income | $4M | $4M | $4M | $5M | $6M | $7M | $7M | $5M | $6M | $7M | $5M | $5M | $5M | $2M | $878.0K | $224.0K | |
| Other Non-op | $-438.0K | $-186.0K | $3M | $-275.0K | $-586.0K | $-221.0K | $-14M | $32.0K | $6M | $7M | $-66.0K | $-93.0K | $-147.0K | $-295.0K | $-31.0K | $116.0K | |
| Income Tax | $0 | $0 | $433.0K | $0 | $0 | $0 | · | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-49M | $-43M | $-68M | $-61M | $-72M | $-85M | $-94M | $-84M | $-68M | $-72M | $-51M | $-45M | $-41M | $-35M | $-38M | $-37M | |
| EPS (Basic) | $-0.55 | $-0.48 | $-0.78 | $-0.70 | $-0.83 | $-0.98 | $-1.09 | $-0.98 | $-0.80 | $-0.85 | $-0.73 | $-0.64 | $-0.59 | $-0.58 | $-0.62 | $-0.63 | |
| EPS (Diluted) | $-0.55 | $-0.48 | $-0.78 | $-0.70 | $-0.83 | $-0.98 | $-1.09 | $-0.98 | $-0.80 | $-0.85 | $-0.73 | $-0.64 | $-0.59 | $-0.58 | $-0.62 | $-0.63 | |
| Shares (Basic) | 88,991,317 | 88,255,636 | · | 86,620,992 | 86,337,237 | 86,171,889 | · | 85,433,569 | 85,274,829 | 85,213,200 | 69,855,766 | 69,638,427 | 69,438,890 | 60,670,294 | 60,156,653 | 58,978,615 | |
| Shares (Diluted) | 88,991,317 | 88,255,636 | · | 86,620,992 | 86,337,237 | 86,171,889 | · | 85,433,569 | 85,274,829 | 85,213,200 | 69,855,766 | 69,638,427 | 69,438,890 | 60,670,294 | 60,156,653 | 58,978,615 | |
| EBITDA | $-40M | $-34M | · | $-57M | $-69M | $-84M | · | $-90M | $-74M | $-80M | $-56M | $-50M | $-46M | $-35M | $-38M | $-37M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $336M | $131M | $135M | $117M | $109M | $154M | $154M | $133M | $105M | $115M | $95M | $97M | $58M | $71M | $120M | $189M | |
| Short-term Investments | $211M | $221M | $259M | $319M | $347M | $358M | $419M | $257M | $320M | $320M | $269M | $302M | $375M | $266M | $247M | $209M | |
| Receivables | · | · | $38M | · | · | · | $8M | · | · | · | · | · | · | · | · | · | |
| Inventory | $33M | $35M | $33M | $25M | $18M | $5M | $366.0K | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $17M | $16M | $13M | $10M | $10M | $8M | $9M | $5M | $4M | $5M | $4M | $3M | $2M | $2M | $2M | $9M | |
| Other Current Assets | · | · | · | · | · | · | · | $4M | $10M | $6M | · | · | · | · | · | · | |
| Current Assets | $675M | $471M | $528M | $530M | $532M | $549M | $603M | $415M | $446M | $454M | $381M | $409M | $442M | $358M | $392M | $420M | |
| PP&E (Net) | $212.0K | $177.0K | $181.0K | $128.0K | $0 | $0 | $0 | $0 | $2.0K | $5.0K | $10.0K | $13.0K | $17.0K | $23.0K | $256.0K | $266.0K | |
| PP&E (Gross) | $646.0K | $606.0K | $606.0K | · | · | · | $419.0K | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $434.0K | $429.0K | $425.0K | · | · | · | $419.0K | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | · | · | · | · | · | · | · | $0 | $156.0K | $248.0K | $587.0K | $579.0K | $693.0K | $881.0K | $995.0K | $1M | |
| Total Assets | $704M | $473M | $530M | $552M | $596M | $641M | $725M | $426M | $477M | $543M | $399M | $431M | $460M | $360M | $406M | $422M | |
| Accounts Payable | $5M | $11M | $17M | $14M | $17M | $10M | $12M | $5M | $12M | $9M | $6M | $11M | $8M | $7M | $6M | $8M | |
| Current Liabilities | $100M | $86M | $120M | $114M | $113M | $95M | $104M | $59M | $42M | $51M | $39M | $30M | $24M | $21M | $31M | $31M | |
| Capital Leases | · | · | · | · | · | · | · | $0 | $133.0K | $327.0K | $851.0K | $1M | $588.0K | $768.0K | $570.0K | $643.0K | |
| Total Liabilities | $689M | $431M | $465M | $436M | $439M | $426M | $437M | $59M | $43M | $51M | $40M | $31M | $24M | $22M | $44M | $48M | |
| Total Debt | $350M | $350M | · | $327M | $331M | $336M | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | $6.0K | |
| Retained Earnings | $-1.60B | $-1.55B | $-1.51B | $-1.44B | $-1.38B | $-1.31B | $-1.22B | $-1.13B | $-1.04B | $-975M | $-830M | $-779M | $-734M | $-654M | $-618M | $-581M | |
| Stockholders' Equity | $15M | $42M | $65M | $115M | $157M | $215M | $288M | $366M | $434M | $492M | $359M | $400M | $436M | $338M | $362M | $375M | |
| Liabilities + Equity | $704M | $473M | $530M | $552M | $596M | $641M | $725M | $426M | $477M | $543M | $399M | $431M | $460M | $360M | $406M | $422M | |
| Shares Outstanding | 89,150,619 | 88,543,881 | 87,405,979 | 86,905,343 | 86,059,077 | 86,047,032 | 85,694,443 | 85,571,205 | 85,028,629 | 84,979,686 | 69,638,168 | 69,431,198 | 68,495,426 | 60,122,661 | 56,399,734 | 55,030,890 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $14M | $12M | $11M | $12M | $14M | $10M | $12M | $12M | $10M | $9M | $8M | $8M | $6M | $4M | $4M | $3M | |
| Operating Cash Flow | $-30M | $-50M | $-69M | $-71M | $-88M | $-95M | $-57M | $-62M | $-72M | $-84M | $-45M | $-35M | $-39M | $-29M | $-40M | $-42M | |
| Investing Cash Flow | $-17M | $38M | $82M | $72M | $42M | $94M | $-269M | $87M | $62M | $-99M | $40M | $74M | $20M | $-7M | $-50M | $8M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | · | · | $0 | · | · | |
| Financing Cash Flow | $253M | $8M | $6M | $6M | $551.0K | $930.0K | $347M | $3M | $676.0K | $2M | $2M | $1M | $2M | $-14M | $22M | $557.0K | |
| Net Change in Cash | $206M | $-4M | $18M | $8M | $-45M | $-90.0K | $21M | $28M | $-9M | $-181M | $-3M | $40M | $-17M | $-49M | $-69M | $-33M |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -54.9% | -52.7% | · | -125.2% | -182.7% | -417.9% | · | -716.6% | -2120.5% | · | · | · | · | · | · | · | |
| Net Margin | -67.8% | -65.8% | · | -132.4% | -189.3% | -423.3% | · | -673.0% | -1944.7% | · | · | · | · | · | · | · | |
| EBITDA Margin | -54.9% | -52.7% | · | -125.2% | -182.7% | -417.9% | · | -716.6% | -2120.5% | · | · | · | · | · | · | · | |
| ROA | -7.6% | -7.7% | · | -12.4% | -13.4% | -14.3% | · | -20.4% | -15.0% | -14.4% | -13.5% | -10.7% | -9.3% | -11.8% | -11.2% | -10.6% | |
| ROE | -57.2% | -33.2% | · | -25.2% | -24.3% | -24.0% | · | -23.2% | -16.3% | -15.6% | -14.7% | -11.7% | -10.2% | -13.2% | -13.0% | -12.3% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.8 | 5.5 | · | 4.6 | 4.7 | 5.8 | · | 7.0 | 10.5 | 8.9 | 9.7 | 13.6 | 18.6 | 17.2 | 12.7 | 13.7 | |
| Quick Ratio | 5.5 | 4.1 | · | 3.8 | 4.0 | 5.4 | · | 6.6 | 10.0 | 8.6 | 9.3 | 13.2 | 18.2 | 16.2 | 11.9 | 13.0 | |
| Debt / Equity | 23.2 | 8.4 | · | 2.8 | 2.1 | 1.6 | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -1649.2 | -1445.7 | -805.1 | -1419.4 | -1150.4 | -20.1 | -54.3 | -56.6 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.17 | $0.47 | · | $1.33 | $1.83 | $2.50 | · | $4.28 | $5.11 | $5.79 | $5.16 | $5.76 | $6.36 | $5.62 | $6.42 | $6.81 | |
| Revenue / Share | $0.82 | $0.73 | · | $0.53 | $0.44 | $0.23 | · | $0.15 | $0.04 | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.57 | · | · | · | $-1.10 | · | · | · | $-0.98 | · | · | $-0.56 | · | · | · | |
| Cash / Share | $3.77 | $1.48 | · | $1.34 | $1.26 | $1.79 | · | $1.55 | $1.24 | $1.35 | $1.36 | $1.40 | $0.84 | $1.19 | $2.13 | $3.43 | |
| EPS (TTM) | $-2.51 | $-2.79 | · | $-3.60 | $-3.88 | $-3.85 | · | $-3.65 | $-3.40 | $-3.24 | $-2.59 | $-2.44 | $-2.42 | $0.01 | $0.19 | $0.37 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $252M | $217M | · | $112M | $78M | $44M | · | $16M | $4M | $0 | · | · | $140M | $140M | $140M | $140M | |
| Net Income TTM | $-221M | $-243M | · | $-312M | $-335M | $-331M | · | $-297M | $-264M | $-241M | $-176M | $-160M | $-153M | $-14M | $818.0K | $15M | |
| Market Cap | $1.95B | $2.07B | · | $1.34B | $806M | $1.06B | · | $1.65B | $1.75B | $2.02B | $1.01B | $1.45B | $1.45B | $1.44B | $1.09B | $956M | |
| Enterprise Value | $1.75B | $2.07B | · | $1.23B | $681M | $881M | · | · | · | · | · | · | · | · | · | · | |
| P/E | -8.7 | -8.4 | · | -4.3 | -2.4 | -3.2 | · | -5.3 | -6.0 | -7.3 | -5.6 | -8.6 | -8.7 | 2403.0 | 101.3 | 47.0 | |
| P/S | 7.7 | 9.5 | · | 12.0 | 10.3 | 24.2 | · | 103.0 | 498.8 | · | · | · | 10.4 | 10.3 | 7.8 | 6.8 | |
| P/B | 129.1 | 49.7 | · | 11.6 | 5.1 | 4.9 | · | 4.5 | 4.0 | 4.1 | 2.8 | 3.6 | 3.3 | 4.3 | 3.0 | 2.6 | |
| P / Tangible Book | 129.1 | 49.7 | · | 11.6 | 5.1 | 4.9 | · | 4.5 | 4.0 | 4.1 | 2.8 | 3.6 | 3.3 | 4.3 | 3.0 | 2.6 | |
| P / Cash Flow | · | -41.1 | · | · | · | -11.1 | · | · | · | -24.2 | · | · | -36.9 | · | · | -22.8 | |
| EV / Revenue | 6.9 | 9.5 | · | 11.0 | 8.7 | 20.1 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -11.5% | -11.9% | · | -23.4% | -41.4% | -31.3% | · | -19.0% | -16.6% | -13.6% | -17.8% | -11.7% | -11.5% | 0.04% | 0.99% | 2.1% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $172M | $24M | $0 | $0 | $140M |
| Margen Operativo % | -158.4% | -1434.4% | · | · | 18.8% |
| Beneficio neto | $-285M | $-319M | $-209M | $-149M | $25M |
| EPS Diluido | $-3.29 | $-3.72 | $-2.98 | $-2.46 | $0.46 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 5.4 | 1.2 | · | · | · |
| Ratio corriente | 4.4 | 5.8 | 10.0 | 16.9 | 21.7 |
| Ratio Rápido | 3.6 | 5.6 | 9.8 | 16.4 | 21.3 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-323M | · | $-161M | $-134M | $29M |
Propietarios institucionales (13F) 263 declarantes · $2.5B total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
263
Valor en tenencia
$2.5B
Nuevas posiciones
37
Posiciones cerradas
36
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 37 (-10 vs trimestre anterior) | 36 (+11 vs trimestre anterior) | 93 (-3 vs trimestre anterior) | 82 (+6 vs trimestre anterior) | +8.7M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| BlackRock, Inc. | $197 177 353 | 9 020 006 | 7,88% | Acciones |
| Kynam Capital Management, LP | $175 993 964 | 8 050 959 | 7,03% | Acciones |
| VANGUARD GROUP INC | $130 899 317 | 6 230 334 | 5,23% | Acciones |
| GOLDMAN SACHS GROUP INC | $128 127 253 | 5 861 265 | 5,12% | Acciones |
| STATE STREET CORP | $123 693 149 | 5 658 424 | 4,94% | Acciones |
| BANK OF AMERICA CORP /DE/ | $88 425 755 | 4 045 094 | 3,53% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $85 863 719 | 3 927 892 | 3,43% | Acciones |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $82 628 614 | 3 779 900 | 3,30% | Acciones |
| Eversept Partners, LP | $61 168 871 | 2 798 210 | 2,44% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $56 499 563 | 2 584 136 | 2,26% | Acciones |
| Hood River Capital Management LLC | $56 055 139 | 2 564 279 | 2,24% | Acciones |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $54 650 000 | 2 500 000 | 2,18% | Acciones |
| FRANKLIN RESOURCES INC | $49 982 872 | 2 286 499 | 2,00% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $44 899 566 | 2 053 960 | 1,79% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $42 010 461 | 1 921 796 | 1,68% | Acciones |
| UBS Group AG | $41 397 375 | 1 893 750 | 1,65% | Acciones |
| Elmind Capital, LP | $40 550 300 | 1 855 000 | 1,62% | Acciones |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $39 133 182 | 1 790 173 | 1,56% | Acciones |
| Candriam S.C.A. | $37 039 763 | 1 696 040 | 1,48% | Acciones |
| Soleus Capital Management, L.P. | $35 588 933 | 1 628 039 | 1,42% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $34 497 812 | 1 578 125 | 1,38% | Acciones |
| ORBIMED ADVISORS LLC | $33 708 120 | 1 542 000 | 1,35% | Acciones |
| Nuveen, LLC | $29 829 610 | 1 364 575 | 1,19% | Acciones |
| MPM BIOIMPACT LLC | $29 150 813 | 1 333 523 | 1,16% | Acciones |
| Aisling Capital Management LP | $28 785 379 | 1 316 806 | 1,15% | Acciones |
| Woodline Partners LP | $27 341 614 | 1 250 760 | 1,09% | Acciones |
| D. E. Shaw & Co., Inc. | $27 105 395 | 1 239 954 | 1,08% | Acciones |
| Catalio Capital Management, LP | $26 575 158 | 1 215 698 | 1,06% | Acciones |
| SILVERARC CAPITAL MANAGEMENT, LLC | $26 546 565 | 1 214 390 | 1,06% | Acciones |
| Prosight Management, LP | $26 232 000 | 1 200 000 | 1,05% | Acciones |
| Trails Edge Capital Partners, LP | $24 264 600 | 1 110 000 | 0,97% | Acciones |
| ALGERT GLOBAL LLC | $22 985 025 | 1 051 465 | 0,92% | Acciones |
| Bank of New York Mellon Corp | $22 736 118 | 1 040 079 | 0,91% | Acciones |
| SPHERA FUNDS MANAGEMENT LTD. | $22 179 287 | 1 014 606 | 0,89% | Acciones |
| LOOMIS SAYLES & CO L P | $20 190 420 | 923 624 | 0,81% | Acciones |
| Parkman Healthcare Partners LLC | $19 176 816 | 877 256 | 0,77% | Acciones |
| Ensign Peak Advisors, Inc | $18 970 786 | 867 831 | 0,76% | Acciones |
| Palo Alto Investors LP | $18 908 594 | 864 986 | 0,76% | Acciones |
| AQR CAPITAL MANAGEMENT LLC | $18 653 226 | 853 304 | 0,75% | Acciones |
| NORTHERN TRUST CORP | $18 483 439 | 845 537 | 0,74% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $17 800 664 | 814 303 | 0,71% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $13 848 507 | 633 509 | 0,55% | Acciones |
| TWO SIGMA ADVISERS, LP | $13 294 120 | 632 752 | 0,53% | Acciones |
| MORGAN STANLEY | $12 875 080 | 588 979 | 0,51% | Acciones |
| Rhenman & Partners Asset Management AB | $12 247 065 | 560 250 | 0,49% | Acciones |
| Apis Capital Advisors, LLC | $12 154 160 | 556 000 | 0,49% | Acciones |
| PANAGORA ASSET MANAGEMENT INC | $11 946 862 | 546 517 | 0,48% | Acciones |
| Qube Research & Technologies Ltd | $10 431 199 | 477 182 | 0,42% | Acciones |
| FIRST TRUST ADVISORS LP | $9 983 462 | 456 700 | 0,40% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9 926 648 | 454 101 | 0,40% | Acciones |
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Access Industries Holdings LLC, AI Life Sciences Investments LLC, AI LSI-SPV LLC, Access Industries Holdings (BVI) L.P., Access Industries, LLC, Access Industries Management, LLC, Len Blavatnik ×2 presentaciones | 4 de marzo de 2022 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 25 insiders · 11 directivos · 15 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Michael A Metzger | Chief Executive Officer | 8 de julio de 2026 M | 484 843 | 0 | 4 | $-1 428 484 |
| Keith A. Goldan | Chief Financial Officer | 1 de junio de 2026 S | 139 252 | 0 | 3 | $-136 994 |
| Daphne Karydas | Chief Financial Officer | 3 de febrero de 2021 A | · | 0 | 0 | $0 |
| Richard P Shea | Chief Financial Officer | 12 de febrero de 2020 A | 7 121 | 0 | 0 | $0 |
| Neil Gallagher | President, Head of R&D | 10 de febrero de 2025 S | 85 095 | 0 | 0 | $0 |
| Nicholas A.J. Botwood | Head of R&D, CMO | 12 de junio de 2026 M | 60 885 | 0 | 2 | $-1 183 643 |
| Peter Ordentlich | Chief Scientific Officer | 15 de febrero de 2023 M | 0 | 0 | 0 | $0 |
| Catherine Madigan | Chief Medical Officer | 2 de febrero de 2023 A | · | 0 | 0 | $0 |
| Alexander Nolte | Chief Accounting Officer | 2 de febrero de 2023 A | 0 | 0 | 0 | $0 |
| Steve M Sabus | Chief Commercial Officer | 5 de diciembre de 2022 A | · | 0 | 0 | $0 |
| Michael L. Meyers | SVP, Chief Medical Officer | 2 de febrero de 2022 A | 23 280 | 0 | 0 | $0 |
| Aleksandra Rizo | Consejero | 4 de febrero de 2026 A | 49 000 | 0 | 0 | $0 |
| Jennifer Jarrett | Consejero | 4 de febrero de 2026 A | 114 000 | 0 | 0 | $0 |
| Martin H. Huber Jr. | Consejero | 4 de febrero de 2026 A | 103 000 | 0 | 0 | $0 |
| Pierre Legault | Consejero | 4 de febrero de 2026 A | 114 000 | 0 | 0 | $0 |
| Keith Katkin | Consejero | 4 de febrero de 2026 A | 124 000 | 0 | 0 | $0 |
| Dennis Podlesak | Consejero | 4 de febrero de 2026 A | 239 763 | 0 | 0 | $0 |
| William Meury | Consejero | 5 de febrero de 2025 A | 90 000 | 0 | 0 | $0 |
| Briggs Morrison | Consejero | 7 de febrero de 2024 A | 34 836 | 0 | 0 | $0 |
| Fabrice Egros | Consejero | 2 de febrero de 2022 A | 32 000 | 0 | 0 | $0 |
| Henry Chen | Consejero | 23 de mayo de 2018 A | · | 0 | 0 | $0 |
| Luke Evnin | Consejero | 23 de mayo de 2018 A | 2 168 691 | 0 | 0 | $0 |
| George W. Sledge Jr. | Consejero | 17 de mayo de 2017 A | · | 0 | 0 | $0 |
| Ivor Royston | Consejero | 20 de marzo de 2017 D | 625 545 | 0 | 0 | $0 |
| Kim P. Kamdar | Consejero | 31 de octubre de 2016 A | · | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 28 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,44% | 74 364 NS | 31 de julio de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,46% | 119 538 NS | 31 de julio de 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,35% | 236 318 NS | 31 de julio de 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,13% | 1 633 NS | 31 de julio de 2026 | N-PORT |
| ESSC · Strategy Shares | 0,11% | 2 142 NS | 31 de julio de 2026 | N-PORT |
| IBB · iShares Trust | 0,11% | 614 605 SH | 11 de septiembre de 2026 | Diario |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,11% | 79 812 NS | 31 de julio de 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,11% | 6 329 SH | 1 de octubre de 2026 | Diario |
| VFMO · VANGUARD WELLINGTON FUND | 0,11% | 104 684 SH | 19 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,11% | 95 455 SH | 19 de agosto de 2026 | Diario |
| IWO · iShares Trust | 0,11% | 836 007 SH | 11 de septiembre de 2026 | Diario |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,07% | 21 409 NS | 31 de julio de 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,06% | 22 921 NS | 31 de julio de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,06% | 512 404 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,05% | 2 273 181 SH | 11 de septiembre de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 78 234 SH | 1 de octubre de 2026 | Diario |
| RSSL · Global X Funds | 0,05% | 42 552 NS | 31 de julio de 2026 | N-PORT |
| ISCG · iShares Trust | 0,05% | 26 742 SH | 11 de septiembre de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,03% | 252 202 SH | 19 de agosto de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 40 330 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 1 013 279 SH | 19 de agosto de 2026 | Diario |
| WSML · iShares Trust | 0,01% | 4 637 SH | 11 de septiembre de 2026 | Diario |
| TILT · FlexShares Trust | 0,01% | 6 640 NS | 31 de julio de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 120 018 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 20 189 SH | 11 de septiembre de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2 825 144 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 7 016 SH | 19 de agosto de 2026 | Diario |
| ISCB · iShares Trust | · | 3 791 SH | 11 de septiembre de 2026 | Diario |
SNDX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 19 analistas
COMPRA
Objetivo mediano
$37.00
+110,2%
8 42,1%
Compra fuerte
10 52,6%
Compra
1 5,3%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
11 analistas · 2026-09-30Objetivo medio $37.55 +113,3%
← Por Debajo de Todos los Objetivos
Precio Actual $17.60
Mín$26.00
Media$37.55
Máx$57.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| SNDX | $1.84B | -6.4 | 627.8% | -165.6% | -257.1% | · |
| STOK | $1.87B | -264.5 | 404.5% | -3.7% | -2.0% | · |
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | · |
| XNCR | $1.10B | -12.3 | 13.7% | -73.2% | -14.0% | · |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | · |
| RARE | $2.22B | -3.9 | 20.2% | -85.4% | -1613.2% | · |
| COAG | · | · | · | · | · | · |
| ANAB | · | -105.4 | 157.0% | · | · | · |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Este Accionista Ganador de Biotecnología Ha Subido un 72%, pero una Reducción de $4 Millones Señala un Liger Reset
Nasdaq · 6 meses, 1 semana atrás
Las acciones de biotecnología suben un 72% ven una venta de $8 millones, pero aquí está el motivo por el que un fondo sigue pareciendo alcista
Nasdaq · 6 meses, 1 semana atrás
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 4, 2026